Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent

Intraperitoneal (IP) chemotherapy is an effective way of treating peritoneal carcinomatosis of colorectal origin after complete cytoreduction. Although IP therapy has been already performed for many years, no standardized treatment design has been developed in terms of schedule, residence time, drug...

Descripción completa

Detalles Bibliográficos
Autores principales: De Smet, L., Ceelen, W., Remon, J. P., Vervaet, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621299/
https://www.ncbi.nlm.nih.gov/pubmed/23589707
http://dx.doi.org/10.1155/2013/720858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621299/
https://www.ncbi.nlm.nih.gov/pubmed/23589707
http://dx.doi.org/10.1155/2013/720858

Ejemplares similares